| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.29 | 0.08 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |